Insider Transactions in Q1 2022 at Icu Medical Inc (ICUI)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 08
2022
|
Brian Michael Bonnell Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,163
-17.52%
|
-
|
|
Mar 08
2022
|
Brian Michael Bonnell Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,209
+24.96%
|
-
|
|
Mar 08
2022
|
Vivek Jain Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,328
-7.89%
|
-
|
|
Mar 08
2022
|
Vivek Jain Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,524
+13.04%
|
-
|
|
Mar 08
2022
|
Kevin J Mc Grody Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
841
+14.79%
|
-
|
|
Mar 08
2022
|
Kevin J Mc Grody Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
442
-9.94%
|
-
|
|
Mar 08
2022
|
Virginia Ruth Sanzone VP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,196
-22.49%
|
-
|
|
Mar 08
2022
|
Virginia Ruth Sanzone VP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
2,272
+29.94%
|
-
|
|
Mar 08
2022
|
Daniel Woolson VP, GM-Infusion Capital |
SELL
Payment of exercise price or tax liability
|
Direct |
894
-7.59%
|
-
|
|
Mar 08
2022
|
Daniel Woolson VP, GM-Infusion Capital |
BUY
Exercise of conversion of derivative security
|
Direct |
2,020
+14.64%
|
-
|
|
Mar 08
2022
|
Christian B. Voigtlander Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,163
-7.92%
|
-
|
|
Mar 08
2022
|
Christian B. Voigtlander Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,209
+13.08%
|
-
|
|
Mar 06
2022
|
Brian Michael Bonnell Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,196
-12.44%
|
$289,432
$242.93 P/Share
|
|
Mar 06
2022
|
Brian Michael Bonnell Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,273
+18.93%
|
-
|
|
Mar 06
2022
|
Vivek Jain Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,692
-5.73%
|
$409,464
$242.93 P/Share
|
|
Mar 06
2022
|
Vivek Jain Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,216
+9.8%
|
-
|
|
Mar 06
2022
|
Kevin J Mc Grody Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
998
-10.58%
|
$241,516
$242.93 P/Share
|
|
Mar 06
2022
|
Kevin J Mc Grody Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,897
+16.71%
|
-
|
|
Mar 06
2022
|
Virginia Ruth Sanzone VP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,599
-23.26%
|
$386,958
$242.93 P/Share
|
|
Mar 06
2022
|
Virginia Ruth Sanzone VP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
3,039
+30.63%
|
-
|
|
Mar 06
2022
|
Daniel Woolson VP, GM-Infusion Capital |
SELL
Payment of exercise price or tax liability
|
Direct |
1,267
-6.35%
|
$153,307
$121.46 P/Share
|
|
Mar 06
2022
|
Daniel Woolson VP, GM-Infusion Capital |
BUY
Exercise of conversion of derivative security
|
Direct |
2,862
+12.54%
|
-
|
|
Mar 06
2022
|
Christian B. Voigtlander Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,576
-6.11%
|
$381,392
$242.93 P/Share
|
|
Mar 06
2022
|
Christian B. Voigtlander Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,995
+10.41%
|
-
|
|
Mar 03
2022
|
Vivek Jain Chairman and CEO |
SELL
Open market or private sale
|
Direct |
36,000
-73.8%
|
$8,640,000
$240.0 P/Share
|
|
Mar 03
2022
|
Vivek Jain Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
36,000
+42.46%
|
$2,088,000
$58.79 P/Share
|